Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by Fundy13on Nov 15, 2018 2:59pm
324 Views
Post# 28981977

Nov 23

Nov 23Friday Nov 23 will be the 30 day mark from when the TRPX deal was announced, so we should see a definitive agreement announced sometime next week.
I do not see this announcement having any imidiate impact on HUGE shares, but should provide a bump to the $10 range for TRPX.
Within a few days of this I would expect to see a lot of the folks who bought TRPX to start moving $ back to HUGE and we might be able to get back to the $0.50-$0.60 range we were seeing before this deal was announced.
This pending deal with TRPX is the single largest factor in HUGE share price dropping the past three weeks.  
Then once we get into the 20 day moving average period it will certainly be in HUGE's best interest to try to gets its SP up so they have to issue as little shares as possible to TRPX shareholders.
TRPX is still the better place to be for now, but that will start to shift soon.
Bullboard Posts